Mineralys Therapeutics, Inc. (MLYS) Insider Trading

Name: Mineralys Therapeutics, Inc. (MLYS) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Oct 2, 2026): Jon Congleton (Chief Executive Officer): Sale of 75,000 shares, $1.91M.

Get alerted when insiders trade MLYS

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta